NASDAQ · IMCC
IM Cannabis financials
$2.45−1.21%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $39.9M | $37.7M | $36.8M | $40.0M | $26.9M |
| Gross profit | $7.1M | $5.9M | $8.2M | $8.3M | $6.8M |
| Gross margin | 17.7% | 15.6% | 22.2% | 20.8% | 25.2% |
| Operating income | -$8.4M | -$7.1M | -$9.7M | -$21.1M | -$18.2M |
| Net income | -$8.2M | -$7.4M | -$7.2M | -$16.6M | -$14.7M |
| Net margin | −20.7% | −19.6% | −19.5% | −41.4% | −54.4% |
| Diluted EPS | $-58.36 | $-94.28 | $-100.76 | $-505.40 | $-1206.00 |
| EBITDA | -$7.0M | -$5.6M | -$6.9M | -$13.9M | -$14.9M |
| Operating cash flow | $3.4M | -$750.5K | -$6.1M | -$9.3M | -$27.2M |
| Free cash flow | $3.4M | -$859.2K | -$6.5M | -$10.5M | -$30.8M |
| Diluted shares | 0.1M | 0.1M | 0.1M | 0.0M | 0.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $2.0M | $601.4K | $1.4M | $1.8M | $11.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $11.6M | $12.2M | $9.4M | $7.1M | $7.8M |
| Total assets | $23.1M | $27.3M | $36.8M | $44.7M | $227.4M |
| Total liabilities | $25.8M | $25.1M | $26.5M | $27.2M | $65.2M |
| Shareholders' equity | -$2.6M | $2.2M | $10.3M | $17.5M | $162.2M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology